Navinta LLC FDA Inspection Record

FEI 3004375014 · Inspections, Form 483s, warning letters and import refusals

Navinta LLC is an FDA-registered facility (FEI 3004375014) located in Ewing, NJ, US. Registered operations: ANALYSIS; API MANUFACTURE. RegDataLab tracks 6 FDA inspections and 1 compliance action at this facility.

What FDA found at this site

Latest inspection
Sep 30, 2024: No Action Indicated (NAI)
Inspections on record
6 (1 OAI, 2 VAI, 3 NAI)
Last OAI inspection
May 16, 2016
Warning letters
1 listed by FDA for this FEI, latest Sep 26, 2016
Recalls as the recalling firm
1, latest Mar 9, 2015

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Sep 30, 2024No Action Indicated (NAI)No citations listed
May 4, 2023No Action Indicated (NAI)No citations listed
Mar 28, 2019Voluntary Action Indicated (VAI)Failure to submit scientific article (21 CFR 314.80(d))
Aug 18, 2017Voluntary Action Indicated (VAI)Late submission of an ICSR (21 CFR 314.80(c)(2)(ii)(B))
Late submission of 15-day report (21 CFR 314.80(c)(1)(i))
Incomplete periodic safety report (21 CFR 314.80(c)(2)(ii)(A))
Failure to maintain records (21 CFR 314.80(j))
May 16, 2016Official Action Indicated (OAI)Failure to develop written procedures (21 CFR 314.80(b))
Interval (21 CFR 314.80(c)(2))
Timely submission (21 CFR 314.81(b)(2))
Aug 10, 2015No Action Indicated (NAI)No citations listed

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Mar 9, 2015Class IID-0431-2015Fomepizole Injection, 1.5 g/1.5 mL (1 g/mL), For Intravenous Infusion only, Rx only…
Lack of Assurance of Sterility. A recent FDA inspection reported GMP violations potentially impacting product quality and sterility.

FDA record score

3 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 17, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

5 records behind this number
RecordDatePoints x age weightAdds
Inspection classified VAIMar 28, 20196 x 0.251.5
Inspection classified VAIAug 18, 20176 x 0.251.5
Warning letter on FDA's dashboard, which does not show close-outsSep 26, 201610 years or older, so it adds no points0
Inspection classified OAIMay 16, 201610 years or older, so it adds no points0
Class II recall D-0431-2015, this FEI as the recalling firmMar 9, 201510 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 16, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 16, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 16, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 16, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Navinta LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Navinta LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Navinta, LLC
Location
Ewing, NJ (US)
Registration Expires
Dec 31, 2027
Operations
ANALYSIS; API MANUFACTURE
Source
decrs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.